Kedrion Biopharma Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2001, the company has established itself as a leader in the development and production of high-quality plasma-derived therapies, catering to patients with rare and chronic conditions. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, all distinguished by their rigorous quality standards and commitment to patient safety. With a strong focus on innovation and sustainability, Kedrion has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. The company is dedicated to improving patient outcomes and continues to make strides in the biopharmaceutical landscape.
We don't have data for Kedrion Biopharma Inc., but we can show you information about their parent organization instead.
View parent company